Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Portuguese Journal of Cardiac Thoracic and Vascular Surgery|January 17, 2025
Tailored Perioperative Medicine For Frail Patients Undergoing Vascular Surgery: A Narrative ReviewBernardo Miguel, Sarah Oliveira, João Valente Jorge, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2015
Population pharmacokinetics of kahalalide F in advanced cancer patientsBernardo Miguel-Lillo, Belén Valenzuela, José Esteban Peris-Ribera, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2008
Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjectsRicardo Nalda-Molina, Belén Valenzuela, Amelia Ramon-Lopez, et al.
SAGE Open Medical Case Reports|February 26, 2019
Gastric mixed adenoneuroendocrine carcinoma case reportMiguel Angel Moyón Constante, Fernando Xavier Moyón Constante, Jorge Fernando Tufiño, et al.
Investigational New Drugs|December 3, 2015
Phase I, dose-escalating study of elisidepsin (Irvalec(®)), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumorsSanjay Goel, Santiago Viteri, Teresa Morán, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2011
Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patientsCarlos Pérez-Ruixo, Belén Valenzuela, Carlos Fernández Teruel, et al.
Investigational New Drugs|May 8, 2015
First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumorsMark J Ratain, David Geary, Samir D Undevia, et al.
Clinical Pharmacokinetics|October 12, 2012
Population pharmacokinetic-pharmacodynamic analysis of neutropenia in cancer patients receiving PM00104 (Zalypsis(®))Mario González-Sales, Belén Valenzuela, Carlos Pérez-Ruixo, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2018
Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approachMyrna Candelaria, Derlis Gonzalez, Francisco Javier Fernández Gómez, et al.
Pain Reports|March 13, 2026
Intravenous galanin (1-16) and a GalR1 agonist attenuate allodynia in rats with spared nerve injuryBernardo Miguel, Marcelo J Villar, Tobías Giovannetti, et al.
Pageof 2